Does race matter in heart failure?

American Heart Journal

Volumn 146, Issue 2, 2003, Pages 203-206

  Yancy, Clyde W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; CARVEDILOL; ENALAPRIL;

CAUCASIAN; DISEASE ASSOCIATION; EDITORIAL; HEART FAILURE; HOSPITALIZATION; KIDNEY FUNCTION; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; SURVIVAL;

EID: 0042627992     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(03)00241-2     Document Type: Editorial

References (15)

1. Dunlap SH, Mallemala S, Sueta CA, et al. Survival rates are similar between African American and white patients with heart failure. Am Heart J 2003;146:265-72.
2. Yancy CW. Heart failure in African Americans: a cardiovascular enigma. J Card Fail 2000;6:183-6.
3. Dries DL, Exner DV, Gersh BJ, et al. Racial differences in the outcome of left ventricular dysfunction. N Engl J Med 1999;341:298.
4. Exner DV, Dries DL, Domanski MJ, et al. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N Engl J Med 2001;344:1351-7.
5. Dries DL, Strong MH, Cooper RS, et al. Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients. J Am Coll Cardiol 2002;40:311-7.
6. Carson P, Ziesche S, Johnson G, et al. Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group. J Card Fail 1999;5:178-87.
7. The Beta-Blocker Evaluation of Survival Trial Investigators. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 2001;344:1659-67.
8. Yancy CW, Fowler MB, Colucci WS, et al. Race and the response to adrenergic blockade with carvedilol in patients with heart failure. N Engl J Med 2001;344:1358-65.
9. Carson P, Fowler MB, Mohacsi P, et al. Effect of carvedilol in black patients with severe heart failure: results of the COPERNICUS Study [abstract]. Circulation 2001;104:11-754.
10. Saunders E. Hypertension in minorities: blacks. Am J Hypertens 1995;8:115-9S.
11. August P. TGF Beta-1 overexpressed in African American hypertensives. Proc Natl Acad Sci U S A 2000;97:3479-84.
12. McNamara DM, Dennis M, Hollubkov R, et al. Genetic risk assessment of cardiac events, GRACE. Circulation 2001;103:1644.
13. Mason DA, Moore JD, Green SA, et al. A gain of function polymorphism in a G-protein coupling domain of the human beta-1 adrenergic receptor. J Biol Chem 1999;274:12670-4.
14. Small KM, Wagoner LE, Levin AM, et al. Synergistic polymorphisms of beta 1 and alpha 2C adrenergic receptors and the risk of congestive heart failure. N Engl J Med 2002;347:1135-42.
15. Franciosa JA, Taylor AL, Cohn JN, et al. African American Heart Failure Trial (A-HeFT): rationale, design, and methodology. J Card Fail 2002;8:128-35.